BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2661988)

  • 1. [A case of juvenile rheumatoid arthritis treated with thymopentin].
    Tucciarone L; Felici W; Greco L; Mechelli A
    Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymopentin in the treatment of alopecia areata.
    Orecchia G
    Dermatologica; 1989; 178(4):231. PubMed ID: 2670621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
    Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
    Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymopentin in the treatment of juvenile chronic arthritis.
    Bardare M; Corona F; Ogliari MT; Cohen E
    Clin Exp Rheumatol; 1990; 8(1):89-93. PubMed ID: 1971780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of thymopentin in the treatment of post-radiation cystitis].
    Martinoli F; Catania G; Bertana F; Caldera G
    Minerva Urol Nefrol; 1988; 40(4):275-6. PubMed ID: 3075095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thymopentin in the treatment of recurrent condylomata acuminata].
    Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M
    Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
    Cantore M; Bucalossi A; Butini P; Carnevali A; Cavion MA; Leoncini L
    G Clin Med; 1989; 70(6-7):421, 423, 425. PubMed ID: 2670653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
    Garozzo G; Granà G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P
    G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymopentin in chronic Trichophyton rubrum infection.
    Molin L; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
    Franchimont P; Hauwaert C; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The protective action of thymopentin on stress damage to the stomach].
    Deviatkina TA; Tarasenko LM; Klusha VE; Tsebrzhinskiĭ OI; Mutsenietse RK
    Biull Eksp Biol Med; 1989 Jun; 107(6):673-5. PubMed ID: 2676006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G; Zöch G; Rath T; Meissl G
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract]   [Full Text] [Related]  

  • 13. An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosis.
    Giordano N; Biasi G; Taddeo A; Marcolongo R; Bertelletti D
    Clin Rheumatol; 1989 Jun; 8(2):293-4. PubMed ID: 2667863
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intra-lesional beta-interferon in combination with systemic thymopentin. Evaluation of results in 35 cases of CIN III and 2 cases of VAIN associated with HPV].
    Osnengo G; Maina G; Gordini G; Durando A; Bertone C
    Minerva Ginecol; 1990 Apr; 42(4):123-8. PubMed ID: 2163035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
    Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
    J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Telethermographic evaluation of the intra-articular administration of thymopentin in rheumatoid arthritis of the knee].
    Pappalardo A; Sallì L; Campisi D; Scalici G; Di Marco C; Martorana U
    Clin Ter; 1989 Mar; 128(5):321-7. PubMed ID: 2524320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for thymopentin as therapeutic agent in rheumatoid arthritis.
    Franchimont P; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():70-5. PubMed ID: 3898295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thymopentin and immune response in patients with cancer].
    Petronella P; Ferrone R; Freda F; Valeriani G
    Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymopentin in dermatology.
    Haneke E
    Curr Probl Dermatol; 1989; 18():283-9. PubMed ID: 2663371
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
    Levinsky RJ; Davies EG; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.